200 related articles for article (PubMed ID: 31637233)
1. A Library Screening Strategy Combining the Concepts of MS Binding Assays and Affinity Selection Mass Spectrometry.
Gabriel J; Höfner G; Wanner KT
Front Chem; 2019; 7():665. PubMed ID: 31637233
[TBL] [Abstract][Full Text] [Related]
2. Combination of MS Binding Assays and affinity selection mass spectrometry for screening of structurally homogenous libraries as exemplified for a focused oxime library addressing the neuronal GABA transporter 1.
Gabriel J; Höfner G; Wanner KT
Eur J Med Chem; 2020 Nov; 206():112598. PubMed ID: 32896797
[TBL] [Abstract][Full Text] [Related]
3. Library screening by means of mass spectrometry (MS) binding assays-exemplarily demonstrated for a pseudostatic library addressing γ-aminobutyric acid (GABA) transporter 1 (GAT1).
Sindelar M; Wanner KT
ChemMedChem; 2012 Sep; 7(9):1678-90. PubMed ID: 22689508
[TBL] [Abstract][Full Text] [Related]
4. Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
Huber SK; Höfner G; Wanner KT
Bioorg Med Chem; 2019 Jul; 27(13):2753-2763. PubMed ID: 31097402
[TBL] [Abstract][Full Text] [Related]
5. Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.
Kern FT; Wanner KT
ChemMedChem; 2015 Feb; 10(2):396-410. PubMed ID: 25369775
[TBL] [Abstract][Full Text] [Related]
6. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
7. Advancing ASMS with LC-MS/MS for the discovery of novel PDCL2 ligands from DNA-encoded chemical library selections.
Ye Q; Belabed H; Wang Y; Yu Z; Palaniappan M; Li JY; Kalovidouris SA; MacKenzie KR; Teng M; Young DW; Fujihara Y; Matzuk MM
Andrology; 2023 Jul; 11(5):808-815. PubMed ID: 36209044
[TBL] [Abstract][Full Text] [Related]
8. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
9. Identification of Pyrrolidine-3-acetic Acid Derived Oximes as Potent Inhibitors of γ-Aminobutyric Acid Transporter 1 through Library Screening with MS Binding Assays.
Huber SK; Höfner G; Wanner KT
ChemMedChem; 2018 Dec; 13(23):2488-2503. PubMed ID: 30485691
[TBL] [Abstract][Full Text] [Related]
10. MS binding assays for GlyT1 based on Org24598 as nonlabelled reporter ligand.
Ackermann TM; Bhokare K; Höfner G; Wanner KT
Neuropharmacology; 2019 Dec; 161():107561. PubMed ID: 30851306
[TBL] [Abstract][Full Text] [Related]
11. High impact technologies for natural products screening.
Koehn FE
Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-ESI-MS/MS quantification method for a potential γ-aminobutyric acid transporter 3 (GAT3) marker and its application in preliminary MS binding assays.
Polley M; Höfner G; Wanner KT
Biomed Chromatogr; 2013 May; 27(5):641-54. PubMed ID: 23225341
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an LC-ESI-MS/MS method for the quantification of D-84, reboxetine and citalopram for their use in MS Binding Assays addressing the monoamine transporters hDAT, hSERT and hNET.
Neiens P; De Simone A; Ramershoven A; Höfner G; Allmendinger L; Wanner KT
Biomed Chromatogr; 2018 Jul; 32(7):e4231. PubMed ID: 29500932
[TBL] [Abstract][Full Text] [Related]
14. Development of MS Binding Assays targeting the binding site of MB327 at the nicotinic acetylcholine receptor.
Sichler S; Höfner G; Rappenglück S; Wein T; Niessen KV; Seeger T; Worek F; Thiermann H; Paintner FF; Wanner KT
Toxicol Lett; 2018 Sep; 293():172-183. PubMed ID: 29146291
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
[TBL] [Abstract][Full Text] [Related]
16. MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1.
Zepperitz C; Höfner G; Wanner KT
ChemMedChem; 2006 Feb; 1(2):208-17. PubMed ID: 16892353
[TBL] [Abstract][Full Text] [Related]
17. Solving the Competitive Binding Equilibria between Many Ligands: Application to High-Throughput Screening and Affinity Optimization.
Blay V; Otero-Muras I; Annis DA
Anal Chem; 2020 Sep; 92(18):12630-12638. PubMed ID: 32812419
[TBL] [Abstract][Full Text] [Related]
18. HAMS: High-Affinity Mass Spectrometry Screening. A High-Throughput Screening Method for Identifying the Tightest-Binding Lead Compounds for Target Proteins with No False Positive Identifications.
Imaduwage KP; Go EP; Zhu Z; Desaire H
J Am Soc Mass Spectrom; 2016 Nov; 27(11):1870-1877. PubMed ID: 27600575
[TBL] [Abstract][Full Text] [Related]
19. Novel Allosteric Ligands of γ-Aminobutyric Acid Transporter 1 (GAT1) by MS Based Screening of Pseudostatic Hydrazone Libraries.
Hauke TJ; Wein T; Höfner G; Wanner KT
J Med Chem; 2018 Nov; 61(22):10310-10332. PubMed ID: 30376325
[TBL] [Abstract][Full Text] [Related]
20. Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
Kern F; Wanner KT
Bioorg Med Chem; 2019 Apr; 27(7):1232-1245. PubMed ID: 30777661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
